Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections
Ended Project Grant Awarded Last action
- Award ID
- R21CA240219
- Recipient
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,017,889
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Funding
-
- $822,138.98 Federal
- $195,750.00 Non-federal
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$11 | $0 | |
| Amendment | $195,750 | $0 | |
| Amendment | $195,750 | $195,750 | |
| Amendment | $234,900 | $0 | |
| Original award | $195,750 | $0 |
Quick answers
Who received award R21CA240219?
R21CA240219 was awarded to New York Stem Cell Foundation Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2019.
How much is award R21CA240219 worth?
$1,017,889 has been obligated on R21CA240219: $822,139 in federal funding and $195,750 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award